Dare Bioscience Inc
(DARE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 7,677 | 9,139 | 1,333 | 480 | 229 |
| Operating Income | -7,677 | -9,139 | -1,333 | -480 | -229 |
| Other Income | 12 | 8 | -296 | -19 | -15 |
| Pre-tax Income | -7,666 | -9,131 | -1,630 | -498 | -244 |
| Net Income Continuous | -7,666 | -9,131 | -1,630 | -498 | -244 |
| Net Income | $-7,666 | $-9,131 | $-1,630 | $-498 | $-244 |
| EPS Basic Total Ops | -10.56 | -28.93 | -3.96 | -6.60 | -3.24 |
| EPS Basic Continuous Ops | -10.60 | -29.01 | -3.92 | -6.57 | -3.22 |
| EPS Diluted Total Ops | -10.56 | -28.93 | -3.96 | -6.60 | -3.24 |
| EPS Diluted Continuous Ops | -10.60 | -29.01 | -3.92 | -6.57 | -3.22 |
| EBITDA(a) | $-2,490 | $-9,139 | $-1,333 | $-480 | $-229 |